Adamis Pharmaceuticals Corp·4

Oct 1, 6:33 PM ET

Marguglio David J. 4

4 · Adamis Pharmaceuticals Corp · Filed Oct 1, 2020

Insider Transaction Report

Form 4
Period: 2020-09-29
Transactions
  • Sale

    Common Stock

    2020-09-29$0.80/sh20,000$16,000308,539 total
Holdings
  • Common Stock

    (indirect: By Children)
    5,884
Footnotes (2)
  • [F1]The sales reported in this Form 4 were for the sole purpose of satisfying or paying income or withholding tax obligations of the undersigned.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at a price $0.80 in each transaction.

Documents

1 file
  • 4
    primary_01.xmlPrimary

    PRIMARY DOCUMENT